Similar positive enrichment was observed when GSEA was performed on an IFNγ-associated gene-set identified in durvalumab-treated non-small cell lung carcinoma (NSCLC) patient tumor biopsies (Higgs et al, 2018) (Fig. 1H). This evidence concerns the gene IFNG and non-small cell lung carcinoma.